Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.470
-0.360 (-19.67%)
At close: Nov 7, 2024, 4:00 PM
1.540
+0.070 (4.75%)
After-hours: Nov 7, 2024, 5:08 PM EST
Anebulo Pharmaceuticals Employees
As of June 30, 2024, Anebulo Pharmaceuticals had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,733,901
Market Cap
38.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 3 | 1 | 50.00% |
| Jun 30, 2023 | 2 | -2 | -50.00% |
| Jun 30, 2022 | 4 | 1 | 33.33% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortress Biotech | 186 |
| Cytosorbents | 186 |
| Vicarious Surgical | 131 |
| Aadi Bioscience | 89 |
| Affimed | 76 |
| Lucid Diagnostics | 70 |
| OncoCyte | 46 |
| Elicio Therapeutics | 32 |
ANEB News
- 6 weeks ago - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 3 months ago - Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects - Business Wire
- 6 months ago - Galehead Development to Collaborate With Rivian Automotive on Renewable Energy Project Development - Business Wire
- 6 months ago - Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 9 months ago - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 1 year ago - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 1 year ago - Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors - Business Wire
- 1 year ago - Anebulo Pharmaceuticals Announces New CEO - Business Wire